About This Item
Product Name
MILLIPLEX® Human Kidney Injury Panel,
description
Configurable Human Kidney Toxicity 4-plex Panel 6
species reactivity
human
packaging
pkg of 1 ea
manufacturer/tradename
Milliplex®
assay range
accuracy: 103-133%, intra-assay cv: <10, sensitivity: 0.10-3.42 ng/mL
(MinDC+2SD), standard curve range: 0.05-50 ng/mL
(β-2-Microglobulin (β2M)), standard curve range: 0.10-100 ng/mL
(RBP4), standard curve range: 0.59-600 ng/mL
(Cystatin C), standard curve range: 2.93-3,000 ng/mL
(Clusterin)
technique(s)
multiplexing: suitable
input
plasma
serum
detection method
fluorometric (Luminex® xMAP® technology)
shipped in
wet ice
storage temp.
2-8°C
General description
Application
Analytes included: β-2-Microglobulin, Clusterin, Cystatin C, Retinol Binding Protein 4 (RBP4)
Assay Characteristics: Refer to kit protocol for assay cross-reactivity, sensitivity, precision, and accuracy.
Features and Benefits
- Multiplex capability for simultaneous detection of 4 analytes
- Magnetic bead-based format compatible with Luminex® xMAP® technology
- Verified biomarkers: β-2-Microglobulin, Clusterin, Cystatin C, Retinol Binding Protein 4 (RBP4)
- Optimized for use with human serum and plasma samples
- Includes all necessary reagents, standards, and controls
- Designed for overnight incubation for enhanced sensitivity
- Conserves sample volume and reduces assay time
- Improves reproducibility and throughput with magnetic bead handling
- Enables comprehensive profiling of kidney injury biomarkers
- Supports toxicology and nephrology research applications
- Streamlines workflow with ready-to-use components
Legal Information
Disclaimer
Label License/Sticker for Assay Product:
By opening the packaging containing this Assay Product (which contains fluorescently labeled microsphere beads authorized by Luminex Corporation) or using this Assay Product in any manner, you are consenting and agreeing to be bound by the End User Terms and Conditions and the End User License Agreement available at http://support.diasorin.com/end-user-terms-and-conditions/. If you do not agree to all of the terms and conditions, you must promptly return this Assay Product for a full refund prior to using it in any manner.
Still not finding the right product?
Explore all of our products under MILLIPLEX® Human Kidney Injury Panel
signalword
Danger
Hazard Classifications
Acute Tox. 3 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Sens. 1 - STOT RE 2
target_organs
Respiratory Tract
Storage Class
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
wgk
WGK 3
Regulatory Information
This item has
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Related Content
Exploring genotoxicity and DNA damage through multiplexing with MILLIPLEX® multiplex genotoxicity assays using Luminex® xMAP® technology enables the high-throughput measurement of phosphorylation levels of multiple proteins simultaneously and reduces sample volume, time, and cost.
Multiplex toxicity assays enable researchers to simultaneously measure multiple toxicity biomarkers of various organs to gain a better understanding of toxicity. Explore how MILLIPLEX® multiplex toxicity assays are advancing research on liver injury, kidney toxicity, genotoxicity, and more.
Novel kidney toxicity biomarkers expand options for acute nephrotoxicity detection. Multiplex assays measure multiple renal damage biomarkers in small sample volumes, minimizing time and costs. See how MILLIPLEX® multiplex kidney toxicity assays detected vancomycin-induced subacute nephrotoxicity in rat models.